White Paper – The Business Case for a Circular MedTech Sector

In Insights

15 April, 2021

This whitepaper demonstrates that the efforts of private companies towards circularity can in fact lead to a more sustainable medtech sector. Sustainable solutions in the field have the potential to not only reduce greenhouse gas emissions, but importantly also address a range of issues related to pollution and waste.

The effects should benefit natural environments and human health alike, and bring the industry in line with the scope of international agreements on sustainability such as the Paris Agreement of 2015. The move towards circularity constitutes a solid business case for competitive medtech companies.

This whitepaper is a result of a joint effort between AWA, Green Innovation Group and Matter.

The Business Case for a Circular MedTech Sector

Download White Paper

Send download link to:

You may also be interested in:

China endorses good-faith commitment when applying for well-known status

From 1 September 2021 applicants and their trademark agents or representing agency will be required to sign and seal

Read more...

The Business of IP – Understanding and Creating Value: Part 5 – Negotiations

In this six-part series, Anders Isaksson explores some of the critical factors and motivators for why companies, small or

Read more...

Determining the Value of Patents during an Investment or Sale

Joanna Applequist and Mikael Henriksson speak on IP matters that companies should consider preparing for during an investment or sale during this seminar

Read more...

Mobile Sliding Menu